RY 141.08 0.0851% TD 77.38 0.8077% SHOP 80.58 -5.633% CNR 174.21 0.0862% ENB 51.67 1.0364% CP 113.34 0.3808% BMO 128.16 0.5729% TRI 229.48 -0.0566% CNQ 104.59 -1.4046% BN 60.46 -0.0496% ATD 75.69 1.244% CSU 3736.3 -2.3672% BNS 65.67 0.1831% CM 67.55 0.5508% SU 54.79 -0.2549% TRP 52.78 1.1111% NGT 58.11 -0.7854% WCN 228.73 0.6778% MFC 35.6 1.1651% BCE 46.39 0.3461%
Last update at 2024-05-10T19:32:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -27.83695M | -11.54324M | -5.08418M | 13.52M | -8.58453M |
Minority interest | 0.64M | -0.03526M | 0.93M | -0.00543M | -0.15252M |
Net income | -28.11255M | -11.14223M | -5.48520M | 31.15M | -8.48557M |
Selling general administrative | 19.21M | 8.49M | 9.35M | 9.77M | 9.60M |
Selling and marketing expenses | 0.66M | 10.58M | 6.62M | 4.83M | 2.08M |
Gross profit | 10.88M | 17.32M | 18.00M | 16.40M | 5.74M |
Reconciled depreciation | 7.97M | 6.48M | 5.31M | 3.55M | 0.96M |
Ebit | -20.25826M | -7.63929M | -2.07907M | -2.07392M | -8.50100M |
Ebitda | -12.45161M | -1.16925M | 3.24M | 1.47M | -7.51512M |
Depreciation and amortization | 7.81M | 6.47M | 5.31M | 3.55M | 0.99M |
Non operating income net other | - | - | - | - | - |
Operating income | -20.25826M | -7.63929M | -2.07907M | -2.07392M | -8.50100M |
Other operating expenses | 83.49M | 69.93M | 54.81M | 33.97M | 16.07M |
Interest expense | 6.51M | 3.90M | 3.20M | 1.81M | 0.11M |
Tax provision | 0.00000M | -0.40102M | 0.40M | 0.00000M | - |
Interest income | 3.12M | 3.35M | 0.04M | 1.63M | 0.12M |
Net interest income | -6.97936M | -4.26879M | -3.15421M | -1.75503M | 0.12M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 0.28M | -0.40102M | 0.40M | -17.62993M | -0.09896M |
Total revenue | 63.23M | 62.29M | 52.05M | 31.77M | 7.57M |
Total operating expenses | 31.14M | 24.96M | 20.77M | 18.60M | 14.24M |
Cost of revenue | 52.35M | 44.97M | 34.05M | 15.36M | 1.83M |
Total other income expense net | -7.57869M | -3.90395M | -3.00511M | 15.59M | -0.08353M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -27.83695M | -11.14223M | -5.48520M | 13.52M | -8.58453M |
Net income applicable to common shares | -27.20056M | -11.17749M | -6.41753M | 13.74M | -8.48557M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 89.55M | 74.78M | 76.40M | 66.16M | 45.98M |
Intangible assets | 0.00000M | 0.15M | 0.15M | - | - |
Earning assets | - | - | - | - | - |
Other current assets | 0.38M | 0.30M | 0.15M | 0.18M | 0.32M |
Total liab | 83.01M | 49.50M | 41.56M | 31.73M | 10.67M |
Total stockholder equity | 6.56M | 24.67M | 35.00M | 34.44M | 35.46M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 12.43M | 7.99M | 8.54M | 4.53M | 0.39M |
Common stock | 72.58M | 64.08M | 53.16M | 55.38M | 53.16M |
Capital stock | 72.58M | 64.08M | 53.16M | 55.38M | 53.16M |
Retained earnings | -54.56966M | -27.36911M | -21.59561M | -7.39126M | -21.13585M |
Other liab | - | 1.19M | 1.17M | - | - |
Good will | 14.20M | 2.91M | 0.66M | - | - |
Other assets | - | 0.27M | 0.51M | - | 2.76M |
Cash | 3.52M | 0.94M | 8.08M | 5.85M | 16.23M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 52.81M | 40.30M | 15.77M | 11.40M | 5.75M |
Current deferred revenue | 0.60M | 0.56M | 0.45M | 0.22M | 0.12M |
Net debt | 62.62M | 35.76M | 27.65M | 23.03M | -10.83567M |
Short term debt | 37.26M | 28.70M | 9.20M | 8.54M | 0.48M |
Short long term debt | 29.81M | 11.34M | 0.15M | 0.64M | 0.53M |
Short long term debt total | 66.14M | 36.71M | 35.73M | 28.87M | 5.39M |
Other stockholder equity | 7.83M | 7.23M | 3.44M | 5.49M | 4.58M |
Property plant equipment | 47.42M | 40.21M | 41.60M | 37.00M | 16.77M |
Total current assets | 27.20M | 30.72M | 32.52M | 27.97M | 26.38M |
Long term investments | 0.53M | 0.53M | 0.93M | 1.15M | 2.76M |
Net tangible assets | - | 21.62M | 31.17M | 34.39M | 35.39M |
Short term investments | - | - | - | - | - |
Net receivables | 2.57M | 5.64M | 5.37M | 5.56M | 2.03M |
Long term debt | 15.59M | 2.48M | 22.93M | 18.51M | 4.92M |
Inventory | 19.82M | 22.59M | 17.86M | 14.96M | 6.35M |
Accounts payable | 2.53M | 3.05M | 1.85M | 0.37M | 4.77M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -19.27415M | -19.27415M | - | -19.04000M | -1.13823M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 55.38M | 53.16M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 0.20M | 0.27M | 0.51M | 38.19M | 19.60M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 62.35M | 44.06M | 43.88M | 38.19M | 19.60M |
Capital lease obligations | 20.74M | 12.17M | 10.69M | 8.58M | - |
Long term debt total | 28.88M | 8.01M | 26.53M | 20.33M | 4.92M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -13.86514M | 0.89M | 0.89M | -14.06700M | -20.52082M |
Change to liabilities | - | 5.80M | 4.28M | -2.29865M | 4.78M |
Total cashflows from investing activities | -13.86514M | -2.86041M | -6.31796M | -14.06700M | -20.52082M |
Net borrowings | - | -4.09567M | 2.13M | 14.60M | 5.39M |
Total cash from financing activities | 16.80M | -3.49830M | 7.04M | 15.81M | 22.03M |
Change to operating activities | - | -0.96493M | -0.43693M | 0.25M | -1.28844M |
Net income | -27.83695M | -11.14223M | -5.48520M | 13.52M | -8.58453M |
Change in cash | -0.72184M | -7.13419M | 2.23M | -10.38305M | -7.31885M |
Begin period cash flow | 4.24M | 8.08M | 5.85M | 16.23M | 23.55M |
End period cash flow | 3.52M | 0.94M | 8.08M | 5.85M | 16.23M |
Total cash from operating activities | -3.65746M | -0.77548M | 1.51M | -12.13037M | -8.82747M |
Issuance of capital stock | 1.72M | 0.00000M | 5.01M | 1.15M | 16.71M |
Depreciation | 7.97M | 6.48M | 5.31M | 3.55M | 0.96M |
Other cashflows from investing activities | -11.50180M | -0.28090M | -0.47952M | -0.03333M | -3.00000M |
Dividends paid | - | - | - | - | - |
Change to inventory | 1.58M | -5.67142M | -6.41828M | -2.23093M | -2.11680M |
Change to account receivables | 1.80M | 0.49M | 0.45M | -3.70463M | -1.71413M |
Sale purchase of stock | 1.72M | 0.00000M | 5.01M | 1.15M | 16.71M |
Other cashflows from financing activities | 46.49M | 1.11M | 5.73M | 16.78M | 5.40M |
Change to netincome | - | 4.68M | 4.30M | -21.44189M | -0.96332M |
Capital expenditures | 2.36M | 2.58M | 5.84M | 14.03M | 17.52M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | 7.62M | -0.75303M | -1.68715M | -7.97932M | -0.33525M |
Stock based compensation | 1.62M | 1.46M | 1.62M | 1.44M | 2.62M |
Other non cash items | 6.97M | 3.18M | 1.75M | -22.65583M | -3.48659M |
Free cash flow | -6.02080M | -3.35498M | -4.33090M | -26.16403M | -26.34829M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
DN Delta 9 Cannabis Inc |
0.005 20.00% | 0.03 | - | 30.03 | 0.07 | 0.65 | 0.96 | -10.9891 |
BHC Bausch Health Companies Inc |
-0.09 0.95% | 9.42 | - | 2.10 | 0.47 | 18.74 | 3.89 | 18.18 |
TLRY Tilray Inc |
-0.06 2.21% | 2.65 | - | 1000.00 | 2.91 | 0.45 | 3.43 | -1.9457 |
CRON Cronos Group Inc |
-0.1 2.56% | 3.80 | - | - | 11.24 | 0.67 | 0.07 | 1.02 |
TSND TerrAscend Corp. |
-0.04 1.73% | 2.27 | - | - | - | - |
Delta 9 Cannabis Inc., together with its subsidiaries, operates as an integrated cannabis company. The company engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis products. Its products include dried cannabis flowers, pre-rolls, and dried sift cannabis, as well as oils, and extracted and derivative products. The company also offers grow pods and live plants to other licensed and pre-licensed companies. In addition, it operates as a medical clinic that provides physician consultation services to patients seeking a medical recommendation for a cannabis prescription. The company operates retail stores under the Delta 9 brand name across the Canadian provinces. It also exports its products to Australia. Delta 9 Cannabis Inc. was incorporated in 2001 and is based in Vancouver, Canada.
P.O. Box 68096, Winnipeg, MB, Canada, R3L 2V9
Name | Title | Year Born |
---|---|---|
Mr. John William Arbuthnot IV | Co-Founder, CEO & Director | 1990 |
Mr. John William Arbuthnot III | Co-Founder & Director | 1954 |
Mr. James Lawson | CFO, Controller & Sec. | 1952 |
Mr. Mark Jonker | Chief Operations Officer | NA |
Mr. Matthew Sodomsky | Chief Technology Officer | NA |
Mr. Derek Reimer | VP of Compliance | NA |
Mr. Marshall Posner | Chief Marketing Officer | NA |
Dr. David M. Kideckel M.B.A., MBA, Ph.D. | Exec. VP and Head of Strategy, Corp. Devel. & Capital Markets | 1980 |
Mr. Ian Chadsey | VP of Corp. Affairs | NA |
Ms. Alexa Goertzen | Sr. Exec. Assistant | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).